
News|Articles|May 16, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 16, 2022
Author(s)Sydney Jennings
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Advertisement
How many fully vaccinated Americans have received a booster dose?
According to the Centers for Disease Control and Prevention (CDC) as of today, May 16, 2022, at 2:15 PM, EDT:
46.4% of fully vaccinated persons in the US have received a booster dose of COVID-19 vaccine.
What percentage of people across age groups in the US have been fully vaccinated?
• 66.4% of total US population
• 70.6% of US population aged ≥5 years
• 74.9% of US population aged ≥12 years
• 76.4% of US population aged ≥18 years
• 90.7% of US population aged ≥65 years
How many cases of COVID-19 have been confirmed in the US?
According to the Johns Hopkins COVID-19 interactive map , as of today, May 16, 2022 at 4:20 PM, EDT, there have been:
• 82 600 106 confirmed cases and
• 999 800 deaths
• 999 800 deaths
In the past 28 days, the 3 states with the most new cases are:
1. New York: 229 366
2. California: 187 269
3. Illinois: 125 519
2. California: 187 269
3. Illinois: 125 519
Deaths: California has the highest number of deaths due to COVID-19 with 90 623 reported fatalities, followed by Texas with 88 226 and Florida with 74 133.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 521 864 627 confirmed cases, 6 266 459 deaths, and 11 418 549 469 vaccine doses administered.
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Clears First At-Home Brain-Stimulation Device for Major Depression
2
Retatrutide Achieves Up to 28.7% Weight Loss and Marked Knee Pain Reduction in Phase 3 TRIUMPH-4 Trial
3
ADA Publishes 2026 Standards of Care With Updates to Sections on Technology, Obesity, Cardiometabolic Disease Management
4
Two Global Phase 3 Trials Confirm Efficacy of Rocatinlimab for People With Moderate-to-Severe Atopic Dermatitis
5





















































































































































































































































































